Pluristem Therapeutics, a developer of placenta-based cell therapies, has been granted a new patent by the Australian Patent Office. Patent #2007228341 covers the method and composition of matter for three-dimensional (3D) expansion of ...
Tags: 3D Cell Expansion, Pluristem
Clinical trials investigating new uses for the anti-cancer drug Avastin have produced mixed results. When combined with standard chemotherapy, Avastin extended the survival of patients with advanced cervical cancer by nearly four months, ...
There is a growing need for Cognitive Rehabilitation Therapy (CRT) due to the huge influx of soldiers returning from war zones with brain injuries, athletes with sports-related head injuries, and the growing population with age-related ...
A group of prominent healthcare experts including bioethicists, pharmacists, policymakers and cancer specialists have proposed concrete steps for preventing and managing a nightmare scenario that is becoming all too common: shortages of ...
Tags: Healthcare, Life-Saving Drugs
TUESDAY Feb. 4, 2014, 2014 -- In a first-of-its-kind initiative, the U.S. National Institutes of Health has partnered with 10 drug companies and several nonprofit groups to speed development of biological ways of diagnosing and treating ...
Tegra Medical Tegra Medical announces the appointment of Mr.J.Mark King as its new Chief Executive Officer. BOSTON,MA,January 15,2014-Tegra Medical is very pleased to announce the appointment of Mr.J.Mark King as its new Chief Executive ...
Tags: Tegra, Tegra Medical, Health care
The Worldwide Innovative Network(WIN)Consortium in personalized cancer medicine is proud to announce that AstraZeneca,DKFZ and EORTC have joined the Consortium.WIN is a unique global network of leading academics,industries,payors and ...
Tags: WIN, cancer medicine, DKFZ, EORTC
Researchers from Massachusetts Eye and Ear,Harvard Medical School,Massachusetts Institute of Technology and Massachusetts General Hospital have demonstrated,for the first time,that aspirin intake correlates with halted growth of vestibular ...
Tags: Aspirin Intake, Aspirin, Intracranial Tumor
TherapeuticsMD,Inc.(NYSE MKT:TXMD),a women's healthcare company("TherapeuticsMD"or the"Company"),announced today that it has initiated the SPRY Trial,a randomized,placebo-controlled phase 3 clinical trial designed to evaluate the safety ...
Their joint aim is to identify new therapeutic targets in ‘triple negative’ breast cancers Curie-Cancer, the body which leads the Institut Curie's industry partner research activity, and Servier, today announce that they have ...
Tags: triple negative, Curie-Cancer, TTK/MPS1, Institut Curie and Servier
A so-called implantable insulin delivery device could one day free people with type 1 diabetes from the need for multiple daily injections, scientists say. "Diabetes is a difficult-to-treat condition, and yet keeping in very good balance ...
US-based Medac Pharma has reported the US Food and Drug Administration (FDA) acceptance of a new drug application (NDA) for its lead product candidate, MPI-2505, a subcutaneous injectable methotrexate (MTX) in a ready-to-use injection ...
CEL-SCI Corporation has received approval from the Medicines and Medical Device Agency of Serbia to begin enrollment of subjects in its Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment ...
INDIANAPOLIS, Jan. 22 (UPI) -- Each year, about half of U.S. adults age 65 and older who are hospitalized must have family assist in medical decision-making, researchers say. Dr. Alexia Torke, an associate professor of medicine at Indiana ...
Tags: Hosital Senior, JAMA, medical dicision
Not prescribing opioids first or as a long-term therapy for chronic, non-cancer pain and avoiding MRIs, CTs and X-rays for low-back pain are among the tests and treatments identified by ASA that are commonly ordered but not always ...